Opportunity ID: 286883

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-16-PRORP-ARA
Funding Opportunity Title: Peer Reviewed Orthopaedic Applied Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 02, 2016
Last Updated Date:
Original Closing Date for Applications: Dec 07, 2016
Current Closing Date for Applications: Dec 07, 2016
Archive Date: Jan 06, 2017
Estimated Total Program Funding: $2,500,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The PRORP Applied Research Award (ARA) mechanism was first offered in FY15. Since then, 44 ARA applications have been received, and 6 have been recommended for funding.
The PRORP ARA seeks applied research applications focused on advancing optimal treatment and restoration of function for military personnel with musculoskeletal injuries sustained during combat or combat-related activities. It is expected that any research findings would also provide benefit to the general population. To meet the intent of the award mechanism, applications must specifically address one and only one of the FY16 PRORP Focus Areas listed in Section I.B. above.
Awards may not be used to support fundamental basic research. Basic research is defined as research directed toward greater knowledge or understanding of the fundamental aspects of phenomena and of observable facts without specific applications toward process or products in mind.
The FY16 PRORP ARA is focused on applied research, defined as work that refines concepts and ideas into potential solutions with a view toward evaluating technical feasibility of promising new knowledge products, pharmacologic agents, behavioral and rehabilitation interventions, diagnostic and therapeutic techniques, clinical guidance, and/or emerging approaches and technologies.
Research Scope: Research proposed under the FY16 PRORP ARA may include small- to large-scale projects. These awards are expected to yield potential health products, approaches, or technologies positioned for human testing. Upon successful completion, the proposed research is expected to yield knowledge products, approaches, or technologies that have the potential to advance toward clinical translation.
Presentation of preliminary data is required: Inclusion of preliminary and/or published data relevant to the research question is required. In addition, investigators must demonstrate logical reasoning. To be competitive, the application must include a sound scientific rationale and a well formulated, testable hypothesis established through a critical review and analysis of the literature.
Studies allowed under the FY16 PRORP ARA may include, but are not limited to:
 Refinement of concepts and ideas into potential solutions with a view toward evaluating technical feasibility of emerging approaches, technologies, and promising new knowledge products.
 Evaluation, maturation, and/or down-selection of potential product candidates (drugs, biologic constructs, or devices/systems) in vitro and/or in vivo.
 Preparation activities needed to support a future clinical trial or regulatory submission.
Awards may not be used to support clinical trials: A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or
efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For more information on how to distinguish clinical research from clinical trials, see the Human Subject Resource Document at https://ebrap.org/eBRAP/public/Program.htm. Investigators seeking support to conduct a clinical trial should apply to the FY16 PRORP Clinical Trial Award (W81XWH-16-PRORP-CTA) mechanism, which can be accessed at http://cdmrp.army.mil/funding/default.shtml.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

301-682-5507
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date

Folder 286883 Full Announcement-FY16 PRORP ARA -> PRORP_FY16 ARA_PA_GG.pdf

Packages

Agency Contact Information: CDMRP Help Desk
301-682-5507
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00226331 Aug 02, 2016 Dec 07, 2016 View

Package 1

Mandatory forms

286883 RR_SF424_2_0-2.0.pdf

286883 RR_Budget_1_3-1.3.pdf

286883 RR_KeyPersonExpanded_2_0-2.0.pdf

286883 PerformanceSite_2_0-2.0.pdf

Optional forms

286883 RR_SubawardBudget30_1_3-1.3.pdf

2025-07-09T18:06:05-05:00

Share This Post, Choose Your Platform!

About the Author: